Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | LJPC | Common Stock | Award | $1.21K | +334 | +2.95% | $3.63 | 11.7K | Mar 31, 2022 | Direct | F1 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | LJPC | Employee Stock Option (Right to Buy) | Award | $0 | +334 | $0.00 | 334 | Mar 31, 2022 | Common Stock | 334 | $4.27 | Direct | F2 |
Id | Content |
---|---|
F1 | These shares were acquired on 3/31/2022 through the La Jolla Pharmaceutical Company 2018 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c). |
F2 | The stock options vest and become exercisable with respect to 25% of the underlying shares on the one-year anniversary of the grant date and then vest and become exercisable ratably on a monthly basis over the next three years. |